Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
L. Quiroga-González
Observed name:
Lara Quiroga-González
Institution:
Agencia Española de Medicamentos y Productos Sanitarios
Observed institution:
Agencia Española de Medicamentos y Productos Sanitarios
ORCID:
0000-0003-2897-5662
Observed ORCID:
0000-0003-2897-5662
OpenAlex ID:
A5066723788
Quantity is not enough: completeness of suspected adverse drug reaction reports in Spain—differences between regional pharmacovigilance centres and pharmaceutical industry
2020
·
C. Fernandez-Fernandez
, E. Lázaro-Bengoa
, et al.
·
European Journal of Clinical Pharmacology
·
22
Síndrome de trombosis con trombocitopenia asociado a vacunas de adenovirus frente a la COVID-19: Epidemiología y presentación clínica de la serie española
2022
·
D. García-Azorín
, E. Lázaro
, et al.
·
Neurología
·
7
PDF
Thrombosis with thrombocytopenia syndrome following adenovirus vector-based vaccines to prevent COVID-19: Epidemiology and clinical presentation in Spain
2024
·
D. García-Azorín
, E. Lázaro
, et al.
·
Neurología (English Edition)
·
2
“Trends and challenges in adverse drug reaction reporting in Spain: Analysis of the FEDRA database (2019–2023)”
2025
·
Cristina Fernandez-Fernandez
, Araceli Núñez Ventura
, et al.
·
European Journal of Clinical Pharmacology
·
1
Show more works
View as search
Works count:
4
Citation count:
32
H-index:
2
I10-index:
1
Year
Topic
Type